USAID grants over $10.5 million for fight against malaria

NewsGuard 100/100 Score

The U.S. government, through the U.S. Agency for International Development (USAID), announced over $10.5 million in grants to seven organizations working in six countries in Africa to extend malaria prevention and control activities in communities most affected by the disease, particularly children under age 5 and pregnant women. The grants were provided through the President's Malaria Initiative (PMI), an interagency initiative led by USAID with the Department of Health and Human Services and the Centers for Disease Control and Prevention as key partners.

The Malaria Communities Program (MCP), a $30 million initiative created under PMI, is providing these grants to support the efforts of communities and indigenous organizations to combat malaria in Africa. The program specifically aims to identify organizations that are new to partnering with the U.S. government and are uniquely positioned to work at the community level. The program also seeks to increase local and indigenous capacities to undertake community-based malaria prevention and treatment activities and to build local ownership of malaria control for the long term. MCP grant recipients will operate within respective PMI country strategies, which have been developed in collaboration with each country's Ministry of Health and National Malaria Control Program, with in-country partners, and with other donor organizations working in-country.

"I am committed to expanding the work of nongovernmental and faith-based organizations, and other community-based entities to reach people with the tools and knowledge to control malaria," said R. Tim Ziemer, U.S. Malaria Coordinator. "The key to saving lives, especially children, is to expand proven approaches and interventions until they reach each and every child who needs them."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New malaria vaccine strain shows promise in preclinical trials